cachexia and recent trials

edit

cachexia links here. Also need updates on the trials that were due to report in 2010. - Rod57 (talk) 13:08, 2 November 2011 (UTC)Reply

Crohns disease

edit

Phase II trial for Crohns disease to run until 2015 also implies that Alder retain the ALD518 name for cancer applications. - Rod57 (talk) 23:08, 3 September 2012 (UTC)Reply

should move BMS-945429 to clazakizumab

edit

Re name: See Promising Phase IIb Data On Clazakizumab In Patients With Moderate-To-Severe Rheumatoid Arthritis .... - Rod57 (talk) 15:12, 24 September 2015 (UTC)Reply

To preserve history here I guess we should bring content from clazakizumab here then rename back ? - Rod57 (talk) 12:13, 20 December 2015 (UTC)Reply

done the merge - now try to rename back - Rod57 (talk) 14:51, 20 December 2015 (UTC)Reply

Requested move 20 December 2015

edit

{{requested move/dated|Clazakizumab}}

BMS-945429Clazakizumab – mAB now has name but there was already a stub - which has now been merged into this. Rod57 (talk) 15:00, 20 December 2015 (UTC)Reply

Now realise I should have just made a 'technical move request' or asked for the target page to be deleted. (I've made the tech-move-request and commented out the request above ) - Rod57 (talk) 02:16, 21 December 2015 (UTC)Reply

Need to clarify Mechanism of action esp re cancer

edit

May only be intended to treat cachexia/weight-loss/fatigue effects of cancer rather than affect the tumour growth directly ? - Rod57 (talk) 17:47, 21 December 2015 (UTC)Reply